Business
InMode to Report Fourth Quarter & Full Year 2023 Financial Results and Hold Conference Call on Feb. 13, 2024, Expects Q4 Revenue Between $126.0M-$126.5M
Conference call to be held on Tuesday, February 13, 2024, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Jan. 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD),
About this update from Inmode Ltd.
[{"type":"text","content":"Conference call to be held on Tuesday, February 13, 2024, at 8:30 a.m. Eastern Time\nYOKNEAM, Israel, Jan. 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year 2023 before the Nasdaq market opens on Tuesday, February 13, 2024.\n\nInMode is currently finalizing its financial results for the fourth quarter and full year of 2023. While complete financial information and operating data are not yet available, set forth below are certain preliminary financial results for said period, subject to final adjustments and other developments that may arise between now and the time such financial results are published. Based on preliminary results, management expects:\nRevenue for the fourth quarter of 2023 to be in the range of $126.0 million to $126.5 million and revenue for the full year of 2023 to be in the range of $491.3 million to $491.8 millionNon-GAAP1 earnings per diluted share for the fourth quarter and full year of 2023 to be in the range of $0.68 to $0.69 and $2.54 to $2.55, respectivelyNon-GAAP1 gross margin for the full year of 2023 to be in the range of 83% to 85%Full year 2024 revenue to be in the range of $495 million to $505 million1Please refer to \"Use of Non-GAAP Financial Measures\" below for important information about non-GAAP financial measures. Non-GAAP results exclude share-based compensation.\nInMode will host a conference call to discuss the fourth quarter and full year 2023 financial results on February 13, at 8:30 a.m. Eastern Time with presentations from management including Moshe Mizrahy, Chairman and Chief Executive Officer; Yair Malca, Chief Financial Officer; Dr. Michael Kreindel, Chief Technology Officer; Shakil Lakhani, President of North America; and Dr. Spero Theodorou, Chief Medical Officer.\nThe Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10185217/fb446e05e4.Callers will receive a unique dial-in upon registration, which enables immediate access on the day of the call. Participants may pre-register at any time, including up to and after the call start time.\nFor callers that opt out of pre-registration, please dial one of the following teleconferencing numbers...